Tempo
Based on 16 publication(s) in Google Scholar
Tempo is a nitric oxide radical and a selective scavenger of ROS in mitochondria. Tempo is also an organocatalyst that disproportionates superoxide and oxidizes primary alcohols to aldehydes in a catalytic cycle. Tempo has mutagenic and antioxidant effects and can induceDNA strand breaks. Tempo also exerts cytotoxic and mutagenic properties in mouse lymphoma cells.
For research use only. We do not sell to patients.
- Purity: 99.63%
- CAS No.: 2564-83-2
- Formula: C9H18NO
- Molecular Weight:156.25
-
Storage:Pure form -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) Tempo
More- Cell. 2026 Mar 31:S0092-8674(26)00279-5. [Abstract]
- Nat Commun. 2025 Nov 28;16(1):10751. [Abstract]
- J Nanobiotechnology. 2025 Nov 25;23(1):737. [Abstract]
- Redox Biol. 2025 Sep 30:87:103881. [Abstract]
- Small Struct. 2025 Oct 17.
- J Immunother Cancer. 2024 Nov 24;12(11):e009805. [Abstract]
- Cell Death Dis. 2025 Apr 5;16(1):254. [Abstract]
- Phytomedicine. 2026 Jul:156:158270. [Abstract]
- Sens Actuators B Chem. 2024 Nov 1.
- J Transl Med. 2024 Nov 28;22(1):1080. [Abstract]
- Biomed Pharmacother. 2024 Nov:180:117510. [Abstract]
- Br J Cancer. 2020 Jul;123(1):126-136. [Abstract]
- Microchem J. 2024 Dec.
- Eur J Pharmacol. 2026 Jun 28:1028:178992. [Abstract]
- FASEB J. 2021 May;35(5):e21445. [Abstract]
- SSRN. 2026 Apr 30.
-
Flow Cytometry
-
WB
-
Flow Cytometry
-
Cell Proliferation/Viability Assay
-
Bio/Physico-chemical Assay
All DNA/RNA Synthesis Isoforms
More
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A-431 | IC50 |
>300 μM
Compound: TEMPO
|
Cytotoxicity against human A431 cells after 72 hrs by MTT assay
Cytotoxicity against human A431 cells after 72 hrs by MTT assay
|
[PMID: 22309911] |
Tempo (1-5 mM; 4 h) can cause DNA damage in L5178Y cells and exert cytotoxicity and genotoxicity[2].
Tempo (1-5 mM; 4 h) causes DNA breaks in mouse lymphoma cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:L5178Y cells and mouse lymphoma cells
-
Concentration:1, 2, 3, 4, 5 mM
-
Incubation Time:4 h
-
Result:Exerted cytotoxicity and genotoxicity in L5178Y cells, and caused DNA-strand breaks in lymphoma cells.
Chemical Information
-
CAS No. 2564-83-2
-
Appearance <36°C Solid,>40°C Liquid
-
Molecular Weight 156.25
-
Formula C9H18NO
-
Color Orange to red
-
SMILES
[O]N1C(C)(C)CCCC1(C)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Pure form -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (16)
-
Journal Impact Factor
-
Most Recent
-
Cell
2026 Mar 31:S0092-8674(26)00279-5. PMID: 41923640 -
Nat Commun
NEK7 couples SDHB to orchestrate respiratory chain electron transport homeostasis that impedes liver fibrosis. [Abstract]2025 Nov 28;16(1):10751. PMID: 41315267
Tempo purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Nov 28;16(1):10751. [Abstract]
Flow cytometry detected mitochondrial ROS levels (MitoSox Red) in HepG2 cells. The HepG2 cells are transfected with NC or si-NEK7 for 48 h, then treated with 500 μM Tempo, 10 μM Dimethyl malonate (DMM), 100 μM Metformin (Met), or 50 nM Rotenone (Rot) for 24 h, respectively.
Tempo purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Nov 28;16(1):10751. [Abstract]
Western blotting analysis of the expression of α-SMA, Collagen Ⅰ, and Fibronectin protein in the LX-2 cells treated with the conditional medium of HepG2 cells. The HepG2 cells are transfected with NC or si-NEK7 for 48 h, then treated with 500 μM Tempo and 10 μM DMM for 24 h, respectively.
-
J Nanobiotechnology
Ion-interference amplifier nano-system enhances radiotherapy via mitochondrial dysfunction and efferocytosis Inhibition. [Abstract]2025 Nov 25;23(1):737. PMID: 41291692 -
Redox Biol
Neutrophil extracellular traps exacerbate inflammatory arthritis by inhibiting γδ Treg cell differentiation via the AIM2 inflammasome. [Abstract]2025 Sep 30:87:103881. PMID: 41046783
Tempo purchased from MedChemExpress. Usage Cited in: Redox Biol. 2025 Sep 30:87:103881. [Abstract]
γδ T cells were treated with Mito-TEMPO (mtT).
-
-
J Immunother Cancer
Propafenone facilitates mitochondrial-associated ferroptosis and synergizes with immunotherapy in melanoma. [Abstract]2024 Nov 24;12(11):e009805. PMID: 39581704
Tempo purchased from MedChemExpress. Usage Cited in: J Immunother Cancer. 2024 Nov 24;12(11):e009805. [Abstract]
Dose response of RSL3-induced death of PPF-treated A375 and SK-MEL-28 cells in the presence of TEMPO (20 µM) or Mito-TEMPO (10 µM) for 6 hours.
Tempo purchased from MedChemExpress. Usage Cited in: J Immunother Cancer. 2024 Nov 24;12(11):e009805. [Abstract]
Mito-lipid peroxidation were measured in A375 and SK-MEL-28 cells after the indicated treatment for 3 hours. PPF, 5 µM; RSL3, 2.5 µM. TEMPO, 20 µM; Mito-TEMPO, 10 µM.
Tempo purchased from MedChemExpress. Usage Cited in: J Immunother Cancer. 2024 Nov 24;12(11):e009805. [Abstract]
PTGS2 mRNA were measured in A375 and SK-MEL-28 cells after the indicated treatment for 3 hours. PPF, 5 µM; RSL3, 2.5 µM. TEMPO, 20 µM; Mito-TEMPO, 10 µM.
-
Cell Death Dis
Inhibition of mitochondrial complex I induces mitochondrial ferroptosis by regulating CoQH2 levels in cancer. [Abstract]2025 Apr 5;16(1):254. PMID: 40185704 -
Phytomedicine
The purified extract of Cremastrae pseudobulbus pleiones pseudobulbus (EPC) induces mitochondrial apoptosis in hepatocellular carcinoma cells through inhibiting a key oncogenic signaling pathway. [Abstract]2026 Jul:156:158270. PMID: 42119450 -
-
J Transl Med
Inhibition of the E3 ligase UBR5 stabilizes TERT and protects vascular organoids from oxidative stress. [Abstract]2024 Nov 28;22(1):1080. PMID: 39609696 -
Biomed Pharmacother
Morusin, a novel inhibitor of ACLY, induces mitochondrial apoptosis in hepatocellular carcinoma cells through ROS-mediated mitophagy. [Abstract]2024 Nov:180:117510. PMID: 39341077 -
Br J Cancer
Isocitrate dehydrogenase 2 contributes to radiation resistance of oesophageal squamous cell carcinoma via regulating mitochondrial function and ROS/pAKT signalling. [Abstract]2020 Jul;123(1):126-136. PMID: 32367071
Tempo purchased from MedChemExpress. Usage Cited in: Br J Cancer. 2020 Jul;123(1):126-136. [Abstract]
Radiation inhibits AKT phosphorylation, and Tempo could alleviate the IDH2 knockdown-induced decrease in AKT phosphorylation in both the steady state and after ROS induction by radiation.
-
-
Eur J Pharmacol
Hyperbaric oxygen therapy alleviates acute carbon monoxide poisoning-induced transition of cardiac fibroblast to myofibroblast and ameliorates cardiac fibrosis via the NRF2/ROS/TGFβ1/Smad pathway. [Abstract]2026 Jun 28:1028:178992. PMID: 42162689 -
FASEB J
2021 May;35(5):e21445. PMID: 33774866 -
Solvent & Solubility
DMSO : 100 mg/mL (640.00 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
H2O : 50 mg/mL (320.00 mM; ultrasonic and warming and heat to 60°C)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (16.00 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (16.00 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Working solution concentration: 0.22 mg/mL
This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.
Purity & Documentation
-
Data Sheet (275 KB)
-
SDS (477 KB)
- English - EN (477 KB)
- Français - FR (477 KB)
- Deutsch - DE (477 KB)
- Norwegian - NO (477 KB)
- Español - ES (477 KB)
- Swedish - SV (477 KB)
- Italian - IT (477 KB)
- Korean - KR (477 KB)
- Portuguese - PT (477 KB)
-
Handling Instructions (2659 KB)
References
[1]. Chen X, et al. Isocitrate dehydrogenase 2 contributes to radiation resistance of oesophageal squamous cell carcinoma via regulating mitochondrial function and ROS/pAKT signalling. Br J Cancer. 2020 May 5. [Content Brief]
[2]. Guo X, et al. Comparative Genotoxicity of TEMPO and 3 of Its Derivatives in Mouse Lymphoma Cells. Toxicol Sci. 2018 May 1;163(1):214-225. [Content Brief]
[3]. Kaur G, et al. Eugenol precludes cutaneous chemical carcinogenesis in mouse by preventing oxidative stress and inflammation and by inducing apoptosis. Mol Carcinog. 2010 Mar;49(3):290-301. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O / DMSO | 1 mM | 6.4000 mL | 32.0000 mL | 64.0000 mL | 160.0000 mL |
| 5 mM | 1.2800 mL | 6.4000 mL | 12.8000 mL | 32.0000 mL | |
| 10 mM | 0.6400 mL | 3.2000 mL | 6.4000 mL | 16.0000 mL | |
| 15 mM | 0.4267 mL | 2.1333 mL | 4.2667 mL | 10.6667 mL | |
| 20 mM | 0.3200 mL | 1.6000 mL | 3.2000 mL | 8.0000 mL | |
| 25 mM | 0.2560 mL | 1.2800 mL | 2.5600 mL | 6.4000 mL | |
| 30 mM | 0.2133 mL | 1.0667 mL | 2.1333 mL | 5.3333 mL | |
| 40 mM | 0.1600 mL | 0.8000 mL | 1.6000 mL | 4.0000 mL | |
| 50 mM | 0.1280 mL | 0.6400 mL | 1.2800 mL | 3.2000 mL | |
| 60 mM | 0.1067 mL | 0.5333 mL | 1.0667 mL | 2.6667 mL | |
| 80 mM | 0.0800 mL | 0.4000 mL | 0.8000 mL | 2.0000 mL | |
| 100 mM | 0.0640 mL | 0.3200 mL | 0.6400 mL | 1.6000 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.